Healthcare Finance News June 17, 2022
The company is leveraging its own portfolio and partner digital assets to directly engage patients at home, virtually or in-person.
Pharmacy retail giant Walgreens announced the launch of a clinical trials business with the aim of boosting access and retention in sponsor-led drug development research by engaging broader and more diverse communities.
The company will use its collection of pharmacy and patient-authorized clinical data to match diverse patient populations to various clinical trials based on race, gender, socioeconomic status, and location.
Walgreens plans to use a combination of in-person and virtual care options, as well as its tech resources, to inform clinical trial designs and optimize trial execution.
“Our commitment to the clinical trials business is another way we are...
Today's Sponsors
Today's Sponsor